Safety and Efficacy of Lenalidomide in Relapsed or Refractory Multiple Myeloma

Lenalidomide is an oral immunomodulatory drug that has helped improve outcomes in multiple myeloma (MM) patients. Combination lenalidomide and dexamethasone (Len+Dex) has been shown to increase response rates and prolong survival compared with dexamethasone alone in patients with relapsed or refract...

Descripción completa

Detalles Bibliográficos
Autores principales: Alegre, Adrian, Vicuña, Isabel, Aguado, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256976/
https://www.ncbi.nlm.nih.gov/pubmed/22253550
http://dx.doi.org/10.4137/CMO.S7275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256976/
https://www.ncbi.nlm.nih.gov/pubmed/22253550
http://dx.doi.org/10.4137/CMO.S7275

Ejemplares similares